Bring regulatory timing into your planning.

Explore potential EMA or MHRA timing windows using product characteristics and recorded regulatory precedent.

Describe the product, clinical package and manufacturing considerations, then examine P50, P75 and P90 estimates with their quantitative basis. Use the range to inform planning discussions and explore the implications for subsequent access milestones.

Plan around a timing range

Describe the product, clinical package and manufacturing considerations relevant to the scenario. Examine the P50, P75 and P90 timing windows rather than relying on a single planning date.

Examine the basis of the estimate

Review the quantitative basis alongside the inputs and recorded regulatory precedent. The relevance of each window depends on how well those inputs and precedents reflect the product under discussion.

These are scenario estimates whose relevance depends on the inputs and precedent available.

Carry timing assumptions into access planning

Use the range to explore later access milestones in Reimbursement Predictor, with the regulatory timing assumption visible when comparing plans.

What the estimate does not answer

Regulatory Predictor estimates timing only. It does not assess whether EMA or MHRA approval will be granted, and a timing window is not an agency commitment.

Request a Regulatory Predictor demonstration